rs780277809
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_144988.4(ALG14):c.179C>G(p.Ser60Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,454 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144988.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG14 | ENST00000370205.6 | c.179C>G | p.Ser60Cys | missense_variant | Exon 2 of 4 | 1 | NM_144988.4 | ENSP00000359224.4 | ||
ALG14-AS1 | ENST00000451611.1 | n.595-2069G>C | intron_variant | Intron 1 of 1 | 1 | |||||
ALG14 | ENST00000495856.1 | n.155C>G | non_coding_transcript_exon_variant | Exon 2 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250862Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135566
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461336Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 726934
GnomAD4 genome AF: 0.000105 AC: 16AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74354
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 15 Uncertain:2
This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 60 of the ALG14 protein (p.Ser60Cys). This variant is present in population databases (rs780277809, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with ALG14-related conditions. ClinVar contains an entry for this variant (Variation ID: 390702). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Inborn genetic diseases Uncertain:1
The c.179C>G (p.S60C) alteration is located in exon 2 (coding exon 2) of the ALG14 gene. This alteration results from a C to G substitution at nucleotide position 179, causing the serine (S) at amino acid position 60 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
The S60C variant in the ALG14 gene has not been reported previously as a pathogenic variant, nor asa benign variant, to our knowledge. The S60C variant was not observed in approximately 6500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The S60C variant is anon-conservative amino acid substitution, which is likely to impact secondary protein structure asthese residues differ in polarity, charge, size and/or other properties. This substitution occurs at aposition that is conserved in mammals and in silico analysis predicts this variant is probably damagingto the protein structure/function. A missense variant in nearby residue (P65L) has been reported in the Human Gene Mutation Database in association with congenital myasthenic syndrome (Stenson et al.,2014), supporting the functional importance of this region of the protein. We interpret S60C as avariant of uncertain significance. -
Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies Uncertain:1
- -
Myopathy, epilepsy, and progressive cerebral atrophy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at